H-1B Dismissed — Biopharmaceutical (2020): the motion to reopen was dismissed because the petitioner

Decision Summary

The motion to reopen was dismissed because the petitioner did not present new facts, but rather restated old arguments and submitted additional evidence without addressing previously noted deficiencies. The motion to reconsider was dismissed because the petitioner failed to demonstrate that the prior decision was based on an incorrect application of law or policy.

Criteria Discussed

Sign up free to download the original PDF